Skip to Content
Find More Like This
Return to Search

Positive modulator of bone morphogenic protein-2

United States Patent

January 27, 2009
View the Complete Patent at the US Patent & Trademark Office
Brookhaven National Laboratory - Visit the Office of Technology Commercialization and Partnerships Website
Compounds of the present invention of formula I and formula II are disclosed in the specification and wherein the compounds are modulators of Bone Morphogenic Protein activity. Compounds are synthetic peptides having a non-growth factor heparin binding region, a linker, and sequences that bind specifically to a receptor for Bone Morphogenic Protein. Uses of compounds of the present invention in the treatment of bone lesions, degenerative joint disease and to enhance bone formation are disclosed.
Zamora; Paul O. (Gaithersburg, MD), Pena; Louis A. (Poquott, NY), Lin; Xinhua (Plainview, NY), Takahashi; Kazuyuki (Germantown, MD)
BioSurface Engineering Technologies, Inc. (College Park, MD), Brookhaven Science Associates (Upton, NY)
11/ 064,039
February 22, 2005
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT This invention was made with United States Government support under contract number DE-AC02-98CH10886, awarded by the U.S. Department of Energy. The United States Government has certain rights in the invention.